Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and treatment
- PMID: 17883973
- DOI: 10.1007/s11894-007-0030-3
Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and treatment
Abstract
The worldwide epidemic of type 2 diabetes mellitus (T2DM) is a substantial economic and social burden. Although gastroparesis associated with type 1 diabetes mellitus (T1DM) has been recognized for years, only recently have studies shown that patients with T2DM also have high rates of gastroparesis. Individuals with T2DM constitute 90% to 95% of the diabetic population. Unique characteristics that distinguish this population are obesity, insulin resistance, and associated comorbidities. These features highlight the importance of investigating gastric emptying in individuals with T2DM and upper gastrointestinal symptoms. The purpose of this review is to examine the literature pertaining to diabetes and the effect of diabetes on gastric neuromuscular function, with a focus on T2DM. An understanding of gastric motility in T2DM is important to diagnose gastroparesis, to treat upper gastrointestinal symptoms, and to restore normal gastric motility, which may lead, in turn, to improved glucose control.
Similar articles
-
Diabetic gastroparesis.Gastroenterol Clin North Am. 2015 Mar;44(1):39-57. doi: 10.1016/j.gtc.2014.11.005. Gastroenterol Clin North Am. 2015. PMID: 25667022 Review.
-
Diabetic gastroparesis: recent insights into pathophysiology and implications for management.Expert Rev Gastroenterol Hepatol. 2013 Feb;7(2):127-39. doi: 10.1586/egh.12.82. Expert Rev Gastroenterol Hepatol. 2013. PMID: 23363262 Review.
-
Delayed Gastric Emptying Associates With Diabetic Complications in Diabetic Patients With Symptoms of Gastroparesis.Am J Gastroenterol. 2019 Nov;114(11):1778-1794. doi: 10.14309/ajg.0000000000000410. Am J Gastroenterol. 2019. PMID: 31658129 Free PMC article.
-
Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes.Neurogastroenterol Motil. 2016 Jul;28(7):1001-15. doi: 10.1111/nmo.12800. Epub 2016 Mar 6. Neurogastroenterol Motil. 2016. PMID: 26946489 Free PMC article. Clinical Trial.
-
Gastroparesis: symptoms, evaluation, and treatment.Gastroenterol Clin North Am. 2007 Sep;36(3):619-47, ix. doi: 10.1016/j.gtc.2007.07.004. Gastroenterol Clin North Am. 2007. PMID: 17950441 Review.
Cited by
-
Cellular pathogenesis of diabetic gastroenteropathy.Minerva Gastroenterol Dietol. 2009 Sep;55(3):315-43. Minerva Gastroenterol Dietol. 2009. PMID: 19829287 Free PMC article. Review.
-
Effect of Gundelia tournefortii extract on diabetic gastropathy: involvement of inflammation, apoptosis, oxidative stress, and histopathology.Vet Res Forum. 2025;16(3):133-139. doi: 10.30466/vrf.2024.2027690.4249. Epub 2025 Mar 15. Vet Res Forum. 2025. PMID: 40391140 Free PMC article.
-
Progressive impairment in gastric and duodenal slow waves and autonomic function during progression of type 2 diabetes in rats.Am J Physiol Gastrointest Liver Physiol. 2025 Apr 1;328(4):G386-G398. doi: 10.1152/ajpgi.00278.2024. Epub 2025 Feb 24. Am J Physiol Gastrointest Liver Physiol. 2025. PMID: 39993032 Free PMC article.
-
Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions.Neurogastroenterol Motil. 2014 May;26(5):611-24. doi: 10.1111/nmo.12330. Epub 2014 Mar 24. Neurogastroenterol Motil. 2014. PMID: 24661628 Free PMC article. Review.
-
Comparison of fasting gastric volume using ultrasound in diabetic and non-diabetic patients in elective surgery: An observational study.Indian J Anaesth. 2020 May;64(5):391-396. doi: 10.4103/ija.IJA_796_19. Epub 2020 May 1. Indian J Anaesth. 2020. PMID: 32724247 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical